Biotechnology Jobs

• USA - Pennsylvania - Upper Providence
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves defining human-relevant mechanistic hypotheses, biomarker strategies, target evaluation, and business development diligence, with matrix influence across clinical, genetics, and portfolio teams.

• Waltham, United States
• Hybrid · 2–3 days in office
• US$151,500 – US$252,500 pa
• Director

Leads cross-functional project teams within Oncology Translational Medicine, coordinating diagnostics, biomarker, clinical development, regulatory and finance activities across internal groups and external partners. Manages integrated timelines, budgets, contracts and invoices, tracks milestones and risks, and supports regulatory documentation and technical evaluations of diagnostic technologies.

Microsoft Project · Microsoft Word · Microsoft Excel +7

• USA - Pennsylvania - Upper Providence
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, ctDNA, flow cytometry and multi-omic analyses to inform dose selection and go/no-go decisions.

IHC/IF · Liquid Biopsy · ctDNA +3

• London
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

• London
• Hybrid
• PLN 419,250 – PLN 698,750 pa
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for Respiratory, Inflammation and Immunology assets in clinical development. Interprets safety data, detects and escalates signals, and delivers evidence-based benefit-risk recommendations to senior governance. Works in a global cross-functional matrix, representing Safety on clinical teams and with regulators.

• Warsaw, Poland
• Hybrid
• PLN 419,250 – PLN 698,750 pa
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for Respiratory, Inflammation and Immunology assets in clinical development. Interprets safety data, detects and escalates signals, and delivers evidence-based benefit-risk recommendations to senior governance. Leads Safety Review Teams and represents Safety on cross-functional clinical matrix teams in a global hybrid environment.

• Siena, Italy
• Hybrid
• €81,750 – €136,250 pa
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators. Hybrid role based in the UK.

• Warsaw, Poland
• Hybrid
• Director
• Permanent

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators and external experts. Hybrid role based in the UK with a global matrix environment.

• London
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and interacts with regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Poznan Grunwaldzka
• Hybrid
• £410,250 – £683,750 pa
• Director

Provides medical and scientific leadership in safety evaluation and risk management for oncology assets in clinical development, interpreting safety data, escalating signals and delivering evidence-based benefit-risk recommendations. Leads Safety Review Teams and cross-functional matrix groups, representing Safety to governance committees and regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.

• Siena, Italy
• Hybrid
• £81,750 – £136,250 pa
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.

• London
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators. Hybrid UK-based role with mentoring and process-improvement duties.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting signals and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. Hybrid role based in the UK with global regulatory and partner interaction.

• London
• Director

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents the Safety Evaluation & Risk Management function on cross-functional clinical matrix and project teams, escalating emerging safety issues to senior governance. Mentors junior staff and partners with Safety Physicians to shape long-term safety strategy.